Outset Medical (OM) Gets a Buy Rating from Leerink Partners

In a report issued on January 24, Danielle Antalffy from Leerink Partners maintained a Buy rating on Outset Medical (OMResearch Report), with a price target of $50.00. The company’s shares closed last Thursday at $38.03.

According to, Antalffy is a 4-star analyst with an average return of 9.1% and a 52.0% success rate. Antalffy covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Treace Medical Concepts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Outset Medical with a $50.00 average price target.

See the top stocks recommended by analysts >>

Based on Outset Medical’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $26.32 million and GAAP net loss of $30.47 million. In comparison, last year the company earned revenue of $13.76 million and had a GAAP net loss of $42.29 million.

Based on the recent corporate insider activity of 81 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OM in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Outset Medical Inc is a medical technology company. The company has developed a machine, Tablo, which reduces the cost and complexity of dialysis.

Read More on OM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More